Page
%P
-
Article
Radiomics predicts risk of cachexia in advanced NSCLC patients treated with immune checkpoint inhibitors
Approximately 50% of cancer patients eventually develop a syndrome of prolonged weight loss (cachexia), which may contribute to primary resistance to immune checkpoint inhibitors (ICI). This study utilised rad...